Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Du musst dich anmelden oder registrieren, bevor du fortfahren kannst.
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Innate Pharma S.a. sell Lokrim

Innate Pharma S.a.
Start price
€2.22
15.12.24 / 20%
Target price
-
15.12.25
Performance (%)
-28.38%
End price
€1.59
16.12.25
Summary
This prediction ended on 16.12.25 with a price of €1.59. The price of Innate Pharma S.a. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -28.38%. Lokrim has 20% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Innate Pharma S.a. - - -
iShares Core DAX® 0,44 % 5,90 % 8,05 %
iShares Nasdaq 100 1,06 % 0,92 % 28,47 %
iShares Nikkei 225® 1,77 % 1,23 % 47,57 %
iShares S&P 500 0,37 % 1,92 % 23,20 %

According to Lokrim what are the pros and cons of Innate Pharma S.a. for the foreseeable future?

Pros
Cons
Business model of the past or high risk
Probably not worthwhile Investment

Comments by Lokrim for this prediction

In the thread Innate Pharma S.a. diskutieren

Sell Innate Pharma S.a.

Lokrim 
0
Report Share
15.12.24 Sell -28.38%
In the thread Trading Innate Pharma S.a.
Prediction Sell
Perf. (%) -28.38%
Target price
Change
Ends at 15.12.25

Die von Lokrim gewählte maximale Laufzeit wurde überschritten

Lokrim 
0
Report Share
16.12.25

Stopped prediction by Lokrim for Innate Pharma S.a.

sell
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€2.40
22.01.24
-
22.01.25
-20.00%
17.08.24

Business model of the past or high risk
Probably not worthwhile Investment
Lokrim 
22.01.24 20%